SCHEMBL16023777

SCHEMBL16023777

Cc1coc2c1C(=O)c1ccc3c(c1C2=O)CCCC3(C)C

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EED O75530 5/20 0.84
▸ SUZ12 Q15022 5/20 0.84
▸ EZH2 Q15910 5/20 0.84
▸ MEN1 O00255 5/20 0.84
▸ ALDH1A1 P00352 5/20 0.84
▸ KMT2A Q03164 5/20 0.84
▸ HIF1A Q16665 4/20 0.84
▸ EPAS1 Q99814 4/20 0.84
▸ CES2 O00748 4/20 0.84
▸ HPGD P15428 4/20 0.84
▸ HSD17B10 Q99714 4/20 0.84
▸ KDM4E B2RXH2 3/20 0.84
▸ MAPT P10636 3/20 0.84
▸ RECQL P46063 3/20 0.84
▸ TDP1 Q9NUW8 3/20 0.84
▸ POLB P06746 2/20 0.84
▸ CES1 P23141 2/20 0.84
▸ PTPN6 P29350 2/20 0.84
▸ PTPN11 Q06124 2/20 0.84
▸ NSD1 Q96L73 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29538928 1.00 EED (0.84) EEDSUZ12EZH2MEN1ALDH1A1
Tanshinone Iia SCHEMBL2026738 0.91 EED (1.00) EEDSUZ12EZH2MEN1ALDH1A1
Isotanshinone Iib SCHEMBL30381469 0.85 EED (0.85) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL16152326 0.79 EED (0.78) EEDSUZ12EZH2MEN1ALDH1A1
Przewaquinone A SCHEMBL16152272 0.77 IDO1 (1.00) EEDSUZ12EZH2MEN1ALDH1A1
Tanshinone Iib SCHEMBL11945767 0.76 EED (1.00) EEDSUZ12EZH2MEN1ALDH1A1
Tanshinone Iib SCHEMBL14417728 0.76 EED (1.00) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL25704333 0.75 EED (0.65) EEDSUZ12EZH2MEN1ALDH1A1
SCHEMBL17663613 0.75 EED (0.77) EEDSUZ12EZH2MEN1ALDH1A1
Methyl Tanshinonate SCHEMBL16152293 0.75 EED (1.00) EEDSUZ12EZH2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114732843-A Traditional Chinese medicine gel patch for treating DPN (dipeptidyl peptidase-IV) through medicine penetration and preparation method and application thereof 上海市浦东新区中医医院 2022-07-12 — — CN disclosed
US-20160022625-A1 TASHINONES AND THEIR DERIVATIVES: NOVEL EXCELLENT DRUGS FOR ALZHEIMER DISEASE THE UNIVERSITY OF AKRON 2016-01-28 — — US disclosed
US-20160022625-A1 TASHINONES AND THEIR DERIVATIVES: NOVEL EXCELLENT DRUGS FOR ALZHEIMER DISEASE THE UNIVERSITY OF AKRON 2016-01-28 — — US disclosed
WO-2014138357-A1 NOVEL TASHINONE DRUGS FOR ALZHEIMER DISEASE THE UNIVERSITY OF AKRON (US) 2014-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022625-A1 TASHINONES AND THEIR DERIVATIVES: NOVEL EXCELLENT DRUGS FOR ALZHEIMER DISEASE APP, HTT, PSEN1 EED 4772/4885SUZ12 4771/4885EZH2 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback